Cell Tracking and Imaging

On this page

Fundamentals of Cell Tracking - Cellular GPS

Cell tracking, a "Cellular GPS," labels cells to monitor their location, migration, and fate in vivo.

  • Definition: Non-invasive methods to observe labeled cells within a living organism over time.
  • Primary Goals:
    • Assess cell therapy effectiveness (e.g., stem cell engraftment).
    • Map immune cell movement in inflammation or infection.
    • Elucidate disease mechanisms (e.g., cancer spread).
  • Key Applications:
    • Regenerative Medicine: Monitoring transplanted cell viability and integration.
    • Oncology: Visualizing tumor metastasis, immune cell anti-tumor activity.
    • Immunology: Investigating immune cell dynamics and interactions.

⭐ Cell tracking is pivotal for evaluating homing efficiency and engraftment of transplanted stem cells.

Modalities for Cell Imaging - Peek-a-Boo Cells

Visualizing tracked cells uses diverse techniques, each with unique strengths and weaknesses. 📌 MRI: Mighty Resolution, Iffy Sensitivity.

  • MRI (Magnetic Resonance Imaging)
    • Principle: SPIOs (Superparamagnetic Iron Oxides) create $T_2^*$ signal void; $^{19}$F imaging.
    • Pros: ↑ High spatial resolution, excellent depth penetration. Cons: ↓ Low sensitivity (requires ~10$^5$-10$^6$ cells).
  • PET (Positron Emission Tomography)
    • Principle: Detects positron-emitting radiotracers (e.g., $^{18}$F-FDG for metabolism; reporter genes like HSV1-tk with $^{18}$F-FHBG).
    • Pros: ↑ High sensitivity (detects ~10$^3$-10$^4$ cells), quantitative. Cons: ↓ Lower resolution than MRI, ionizing radiation.

    ⭐ PET offers high sensitivity for detecting small numbers of cells but often requires genetic modification for reporter gene strategies.

  • SPECT (Single Photon Emission Computed Tomography)
    • Principle: Detects gamma-emitting radiotracers (e.g., $^{111}$In-oxine).
    • Pros: More accessible & cheaper than PET. Cons: ↓ Lower sensitivity & resolution than PET, ionizing radiation.
  • Optical Imaging (Bioluminescence - BLI / Fluorescence - FLI)
    • Principle: BLI (luciferase-substrate reaction), FLI (excitation & emission).
    • Pros: ↑↑ Very high sensitivity (detects <1000 cells), cost-effective, fast. Cons: ↓ Poor depth penetration (superficial).
  • Ultrasound (US)
    • Principle: Microbubble contrast agents or echogenic gene reporters.
    • Pros: Real-time, non-ionizing, portable, low cost. Cons: ↓ Lower sensitivity & resolution, operator dependent.
ModalitySensitivityResolutionDepth PenetrationQuantificationCost
MRI↓ (10$^5$-10$^6$)↑ HighExcellentModerateHigh
PET↑ (10$^3$-10$^4$)ModerateGoodExcellentHigh
SPECTModerate↓-ModerateGoodModerateModerate
Optical (BLI/FLI)↑↑ (<1000)↓ LowPoorGoodLow
Ultrasound↓ LowModerateFairLimitedLow

Cell Labeling Techniques - Tag, You're Imaged!

Cells are made detectable via two main strategies:

  • Direct Labeling: Cells directly loaded with contrast agents (ex vivo/in vivo).

    • Agents: SPIOs, perfluorocarbons, radionuclides ($^{111}\text{In}$, $^{99m}\text{Tc}$), fluorescent dyes, quantum dots.
    • Pros: Simpler. Cons: Signal dilution with division, toxicity. 📌 DIRect = Dye In Right away.
  • Indirect Labeling (Reporter Genes): Cells genetically modified to express reporter proteins.

    • Genes: HSV1-tk (PET), Luciferase (BLI), Ferritin (MRI).
    • Pros: Stable signal, reflects viability, longitudinal tracking. Cons: Complex, immunogenicity.

FeatureDirect LabelingIndirect Labeling (Reporter Gene)
MechanismAgent uptakeGene expression
Signal/DivisionDilutesStable/Amplifies
Viability LinkWeakStrong
LongitudinalLimitedExcellent
Loading diagram…

Limitations & Advances - The Next Frontier

  • Limitations:
    • Sensitivity: Low detection of small cell numbers.
    • Specificity: Distinguishing cells from background noise.
    • Quantification: Inaccurate cell number assessment.
    • Toxicity: Label-induced cell damage/functional alteration.
    • Dilution: Signal loss with cell division.
    • Long-term Tracking: Signal decay, label clearance.
    • Immunogenicity: Immune reactions to labels/proteins.
    • Regulatory Hurdles: Complex approval processes.
  • Advances & Future Outlook:
    • Multimodal imaging (e.g., PET-MRI).
    • Theranostics: Combined diagnosis & therapy.
    • Novel biocompatible/stealth labels.

⭐ A major hurdle in clinical cell tracking is ensuring that the labeling process does not adversely affect cell viability, function, or migratory capacity.

High‑Yield Points - ⚡ Biggest Takeaways

  • Direct cell labeling: ex vivo introduction of agents (e.g., 111In, SPIOs).
  • Indirect labeling: uses reporter genes (e.g., HSV1-tk for PET) for detectable protein expression.
  • 111In-oxine & 99mTc-HMPAO track leukocytes in infection/inflammation.
  • SPIOs for MRI tracking cause T2* signal loss.
  • BLI/FLI: high sensitivity, but limited to superficial/preclinical studies due to poor penetration.
  • Label dilution with cell division is a key limitation of direct methods.
  • Reporter gene imaging allows longitudinal tracking and cell viability assessment.

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Cell Tracking and Imaging

  1. 1. IFN-gamma is produced by

    • A. Macrophages
    • B. T-cells
    • C. Neutrophils
    • D. B-cells
    Show answer

    Answer: B. T-cells

    T-cells - T-cells, particularly Th1 cells and cytotoxic T lymphocytes, are major producers of IFN-γ after activation. - IFN-γ promotes type 1 immune responses and contributes to antiviral, antitumor, and macrophage-activating immunity; NK cells can also produce it. B-cells - B-cells are primarily responsible for humoral immunity, including antibody production and antigen presentation, rather than being major producers of IFN-γ. - Their cytokine repertoire more typically includes IL-10, IL-6, and lymphotoxin, so this option does not fit the principal source of IFN-γ. Macrophages - Macrophages respond to IFN-γ by undergoing activation, but they are not its primary cellular source. - They mainly produce cytokines such as IL-1, IL-6, TNF-α, and IL-12 during infection or inflammation, distinguishing them from IFN-γ-producing T-cells. Neutrophils - Neutrophils are innate phagocytes that primarily eliminate pathogens through phagocytosis, degranulation, and NETosis. - They are not a significant source of IFN-γ, so their principal antimicrobial functions do not support this choice.

  2. 2. What is the most likely diagnosis on the thyroid scintigraphy shown?

    • A. Papillary cancer thyroid
    • B. Graves' disease
    • C. Lateral aberrant thyroid
    • D. Hypersecreting adenoma
    Show answer

    Answer: D. Hypersecreting adenoma

    Hypersecreting adenoma - A hypersecreting adenoma appears as a single intensely hot nodule, reflecting increased radioactive tracer uptake by autonomously functioning tissue. - Autonomous hormone production suppresses the remaining thyroid, producing reduced uptake in surrounding tissue and identifying a toxic adenoma. Papillary cancer thyroid - Papillary thyroid carcinoma typically appears as a cold nodule because malignant tissue usually has reduced or absent radioactive iodine uptake. - A single intensely hot nodule instead indicates autonomous hormone production, making papillary cancer inconsistent with the described scan pattern. Graves' disease - Graves disease causes diffuse, symmetrical increased uptake throughout the thyroid, reflecting generalized gland hyperactivity. - The scan describes a localized hot nodule with suppression of surrounding thyroid tissue, which favors an autonomous adenoma rather than Graves disease. Lateral aberrant thyroid Lateral aberrant thyroid conventionally denotes thyroid carcinoma metastatic to a lateral cervical lymph node, usually from papillary thyroid carcinoma. It does not describe the autonomously functioning intrathyroidal nodule demonstrated here.

  3. 3. Identify the intracellular hyaline body.

    • A. Hyaline droplets
    • B. Mallory Hyaline bodies
    • C. Corpora amylacea
    • D. Russell bodies
    Show answer

    Answer: D. Russell bodies

    Russell bodies are the rounded eosinophilic inclusions visible within the plasma-cell cytoplasm. They represent immunoglobulin retained in dilated rough endoplasmic reticulum. Hyaline droplets are protein-reabsorption droplets in renal tubular epithelial cells rather than inclusions in plasma cells. Mallory Hyaline bodies are irregular keratin aggregates in hepatocytes rather than rounded immunoglobulin globules. Corpora amylacea are typically laminated bodies and do not match these plasma-cell inclusions.

  4. 4. Which of the following substances is toxic to parasites?

    • A. Eosinophil peroxidase
    • B. Interleukin-2
    • C. Interleukin-6
    • D. Leukocyte interferon-alpha
    Show answer

    Answer: A. Eosinophil peroxidase

    Eosinophil peroxidase - Peroxidase enzymes, especially from eosinophils, generate toxic oxygen metabolites and hypohalous acids that damage and kill parasites. - This mechanism is particularly important in defense against larger parasites, including helminths (worms), which are targeted by eosinophil-mediated cytotoxicity. Interleukin-2 - IL-2 primarily promotes proliferation and differentiation of T cells, thereby supporting adaptive immune responses rather than directly killing parasites. - Although IL-2 can enhance immune-cell activity, it lacks the direct parasiticidal toxicity characteristic of eosinophil peroxidase. Interleukin-6 - IL-6 is a pleiotropic cytokine involved in inflammation, acute-phase responses, and lymphocyte differentiation, not direct parasite toxicity. - Its role is mainly immune regulation, so it does not generate the toxic oxygen metabolites or hypohalous acids that damage parasites. Leukocyte interferon-alpha - Leukocyte interferon-alpha primarily provides antiviral effects and activates natural killer cells rather than directly acting as a toxic substance against parasites. - Although it modulates immune responses, its distinguishing function is antiviral immunity, not eosinophil-mediated parasiticidal activity.

  5. 5. In rheumatoid synovium, which infiltrating cells are a major source of TNF, IL-1 and IL-6?

    • A. Dendritic cells
    • B. CD4+ Helper cells
    • C. Macrophages
    • D. Neutrophils
    Show answer

    Answer: C. Macrophages

    Macrophages are a major source of TNF, IL-1 and IL-6 in rheumatoid synovium. These cytokines sustain inflammation and promote joint damage. CD4+ Helper cells coordinate adaptive immune responses but are not the characteristic source of this macrophage cytokine combination. Dendritic cells chiefly present antigen and activate T cells. Neutrophils are prominent in inflammatory synovial fluid but are not the principal synovial source targeted by this question.

  6. 6. Which radionuclide labels the glucose analogue most commonly used for PET imaging?

    • A. Fluorine 18
    • B. Nitrogen 13
    • C. Carbon 11
    • D. Oxygen 15
    Show answer

    Answer: A. Fluorine 18

    Fluorine 18 - Fluorine-18 is the radioactive component of 18F-FDG, the most commonly used PET tracer administered as a glucose analogue. - FDG mimics glucose, enters metabolically active cells, and enables PET imaging of regional glucose metabolism. Oxygen 15 - Oxygen-15 is a positron-emitting radionuclide used in PET tracers such as 15O-water for assessing cerebral blood flow, not as the usual glucose analogue. - Its approximately 2-minute half-life requires rapid production and limits routine clinical use, making it unsuitable as the common glucose-based PET tracer. Carbon 11 - Carbon-11 can label PET tracers such as 11C-methionine, but it is not the usual radionuclide used in glucose-based PET imaging. - Its approximately 20-minute half-life requires an on-site cyclotron, limiting availability compared with 18F-FDG. Nitrogen 13 - Nitrogen 13 is used in 13N-ammonia for myocardial perfusion PET, not in the routinely used glucose analogue 18F-FDG.

  7. 7. Which method is the diagnostic reference standard for distinguishing cerebral radiation necrosis from recurrent tumor after radiotherapy?

    • A. Positron emission tomography
    • B. Computed tomography
    • C. Magnetic resonance imaging
    • D. Biopsy
    Show answer

    Answer: D. Biopsy

    Biopsy - Biopsy is the definitive diagnostic method because histological examination can directly demonstrate necrosis and associated cellular changes. - Tissue examination also helps exclude residual or recurrent malignancy, which imaging studies may not reliably distinguish from radiation-induced necrosis. Positron emission tomography - Positron emission tomography may help distinguish recurrent tumor from radiation necrosis by metabolic uptake, but inflammatory changes in necrosis can cause increased uptake and false-positive results. - Because of this limited specificity, Positron emission tomography is less definitive than tissue examination and cannot reliably establish the diagnosis alone. Computed tomography - Computed tomography may demonstrate low-density lesions, edema, or mass effect associated with radiation injury, but these findings are not specific for necrosis. - It has limited sensitivity for distinguishing radiation necrosis from residual or recurrent tumor, so it cannot definitively establish the diagnosis. Magnetic resonance imaging - Magnetic resonance imaging can show T1 hypointensity, T2 hyperintensity, edema, and mass effect in radiation necrosis, but these structural findings are nonspecific. - Magnetic resonance imaging often cannot reliably differentiate radiation necrosis from tumor recurrence, making it supportive rather than definitive for diagnosis.

  8. 8. The following image shows:

    • A. Whole body MRI scan
    • B. Bone scintigraphy
    • C. Whole body CT scan
    • D. Plain radiography
    Show answer

    Answer: B. Bone scintigraphy

    Bone scintigraphy - Bone scintigraphy displays the skeleton through radioactive tracer distribution, with diffuse uptake and focal hot spots reflecting increased bone turnover. - The displayed skeleton, extending from the skull to the proximal thighs, shows the tracer-distribution pattern of planar bone scintigraphy. Whole body CT scan - Whole-body CT depicts cross-sectional anatomy using X-ray attenuation, with detailed bone density and soft-tissue structures rather than tracer distribution. - The described diffuse skeletal uptake and focal hot spots indicate radionuclide activity, not the structural imaging pattern of CT. Plain radiography - Plain radiography produces two-dimensional shadow-like images from differential X-ray absorption, emphasizing bone contours and density. - It does not use a radioactive tracer, so it cannot demonstrate diffuse skeletal uptake or focal areas of increased bone turnover. Whole body MRI scan - Whole-body MRI provides detailed anatomical and soft-tissue contrast with signal intensities determined by tissue composition and imaging sequence. - MRI can assess bone marrow, but it does not produce the uniform radionuclide-based skeletal signal and hot spots described here.

  9. 9. Which imaging modality is shown?

    • A. PET scan
    • B. MUGA scan
    • C. PET-CT
    • D. HIDA scan
    Show answer

    Answer: C. PET-CT

    PET-CT - PET-CT combines PET-derived metabolic activity with CT-derived anatomical detail, allowing tracer uptake to be localized to specific organs and structures. - The image shows colour-coded tracer uptake overlaid with grayscale anatomical outlines, including skeletal and organ detail, which is characteristic of fused PET-CT imaging. MUGA scan - MUGA scanning evaluates cardiac function by tracking labelled blood-pool activity through the heart chambers, commonly to calculate ejection fraction. - The depicted study is a whole-body fusion image, rather than a cardiac-focused dynamic examination assessing chamber motion. PET scan - PET scanning demonstrates radiotracer metabolism and areas of increased uptake, but generally provides less precise anatomical structural detail when viewed alone. - The image combines metabolic colour information with clear anatomical outlines, indicating CT-based fusion rather than standalone PET imaging. HIDA scan - HIDA scanning uses hepatobiliary tracer uptake to assess the liver, gallbladder, bile ducts, and biliary drainage. - It would display a focused hepatobiliary study, not a comprehensive whole-body image combining metabolic activity with cross-sectional anatomical information.

  10. 10. Tyrosine kinase receptor is associated with proto-oncogene -

    • A. RAS
    • B. RET
    • C. RB
    • D. MYC
    Show answer

    Answer: B. RET

    RET (REarranged during Transfection) - RET encodes a receptor tyrosine kinase involved in cell signaling and development, fitting the proto-oncogene association described. - Activating alterations in RET are associated with medullary thyroid carcinoma and multiple endocrine neoplasia type 2. MYC (Myelocytomatosis oncogene) - MYC is a proto-oncogene encoding a transcription factor that promotes cell-cycle progression and growth, rather than forming a tyrosine kinase receptor. - Although MYC can drive cellular proliferation when dysregulated, it does not possess receptor tyrosine kinase activity. RAS (RAt Sarcoma) - RAS is an oncogenic GTPase that transmits intracellular signals downstream of receptors, rather than functioning as a receptor itself. - Although activating RAS mutations promote neoplasia, RAS lacks the transmembrane tyrosine kinase structure characteristic of RET. RB (Retinoblastoma gene) - RB is a tumor suppressor gene, not a proto-oncogene encoding a tyrosine kinase receptor. - The RB protein regulates the cell cycle by limiting excessive proliferation, so it does not have receptor signaling activity.

Flashcards: Cell Tracking and Imaging

  1. 1. is a radioactive PET imaging agent that is used to estimate the density of aggregated neurofibrillary tangles in Alzheimer's disease

    Show answer

    Flortaucipir F18

  2. 2. C11 Methionine PET is done for the

    Show answer

    brain tumor.

  3. 3. Which compounds in molecular imaging are used for the diagnosis of neuroendocrine tumors?

    Show answer

    68Ga-DOTATOC, 68Ga-DOTATATE, and 68Ga-DOTANOC

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF